Invesaro

Stocks KNSA Earnings

Earnings

Kiniksa Pharmaceuticals International, plc (KNSA) earnings

Quarterly results of Kiniksa Pharmaceuticals International, plc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when KNSA files with the SEC.

Next earnings date

Kiniksa Pharmaceuticals International, plc is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Kiniksa Pharmaceuticals International, plc reported revenue of $286M (+58.1% on the same quarter a year earlier) and net income of $47.3M (+156.8% on the same quarter a year earlier).

Diluted earnings per share were $0.56 (+143.5% on the same quarter a year earlier).

Filed with the SEC on October 27, 2026.

Revenue by quarter
Q4 24: $122.5M $122.5M Q4 24Q1 25: $137.8M $137.8M Q1 25Q2 25: $156.8M $156.8M Q2 25Q3 25: $180.9M $180.9M Q3 25Q4 25: $202.1M $202.1M Q4 25Q1 26: $214.3M $214.3M Q1 26Q2 26: $243.6M $243.6M Q2 26Q3 26: $286M $286M Q3 26
Net income by quarter
Q4 24: -$8.9M -$8.9M Q4 24Q1 25: $8.5M $8.5M Q1 25Q2 25: $17.8M $17.8M Q2 25Q3 25: $18.4M $18.4M Q3 25Q4 25: $14.2M $14.2M Q4 25Q1 26: $22.6M $22.6M Q1 26Q2 26: $25.4M $25.4M Q2 26Q3 26: $47.3M $47.3M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$286M+58.1%$47.3M$0.56
Q2 FY2026June 30, 2026$243.6M+55.4%$25.4M$0.30
Q1 FY2026March 31, 2026$214.3M+55.5%$22.6M$0.27
Q4 FY2025December 31, 2025$202.1M+65%$14.2M-
Q3 FY2025September 30, 2025$180.9M-$18.4M$0.23
Q2 FY2025June 30, 2025$156.8M-$17.8M$0.23
Q1 FY2025March 31, 2025$137.8M-$8.5M$0.11
Q4 FY2024December 31, 2024$122.5M--$8.9M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Kiniksa Pharmaceuticals International, plc's next earnings date?

Kiniksa Pharmaceuticals International, plc is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Kiniksa Pharmaceuticals International, plc's latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Kiniksa Pharmaceuticals International, plc reported revenue of $286M and net income of $47.3M (+156.8% on the same quarter a year earlier). The figures come from its filing with the SEC.

Is Kiniksa Pharmaceuticals International, plc's revenue growing?

Revenue in Q3 FY2026 was $286M, up 58.1% from $180.9M in the same quarter a year earlier.

Get an email when KNSA reports

Follow KNSA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when KNSA files with the SEC.

Source: quarterly figures Kiniksa Pharmaceuticals International, plc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Kiniksa Pharmaceuticals International, plc